Tomas Mow

1.3k total citations · 1 hit paper
26 papers, 961 citations indexed

About

Tomas Mow is a scholar working on Cardiology and Cardiovascular Medicine, Small Animals and Molecular Biology. According to data from OpenAlex, Tomas Mow has authored 26 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Small Animals and 7 papers in Molecular Biology. Recurrent topics in Tomas Mow's work include Computational Drug Discovery Methods (7 papers), Animal testing and alternatives (7 papers) and Cardiovascular Conditions and Treatments (5 papers). Tomas Mow is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Animal testing and alternatives (7 papers) and Cardiovascular Conditions and Treatments (5 papers). Tomas Mow collaborates with scholars based in Denmark, United Kingdom and Switzerland. Tomas Mow's co-authors include Henrik D. Pedersen, Jorrit J. Hornberg, Mikael Persson, Lisbeth H. Olsen, Bruno Pouzet, M.L. Laursen, Annemette Thougaard, J. Koch, T. Falk and Jens Häggström and has published in prestigious journals such as Nature Reviews Drug Discovery, British Journal of Pharmacology and Psychopharmacology.

In The Last Decade

Tomas Mow

26 papers receiving 928 citations

Hit Papers

The evolving role of investigative toxicology in the phar... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Mow Denmark 14 282 264 238 150 103 26 961
Nadja Grobe United States 19 279 1.0× 269 1.0× 24 0.1× 20 0.1× 75 0.7× 57 1.1k
Pascal Champéroux France 18 333 1.2× 344 1.3× 40 0.2× 29 0.2× 17 0.2× 53 904
M Hichens United States 27 631 2.2× 368 1.4× 51 0.2× 42 0.3× 107 1.0× 52 1.9k
Vikrant Vijay United States 15 265 0.9× 187 0.7× 17 0.1× 120 0.8× 209 2.0× 29 835
John Koerner United States 17 347 1.2× 505 1.9× 33 0.1× 81 0.5× 14 0.1× 33 753
Duncan Armstrong United Kingdom 13 279 1.0× 200 0.8× 37 0.2× 98 0.7× 41 0.4× 20 744
Joseph J. DeGeorge United States 17 325 1.2× 43 0.2× 19 0.1× 64 0.4× 73 0.7× 40 821
Helen Prior United Kingdom 14 213 0.8× 157 0.6× 15 0.1× 57 0.4× 33 0.3× 47 599
Shohei Higuchi Japan 16 213 0.8× 65 0.2× 53 0.2× 22 0.1× 115 1.1× 75 948
Jin Sook Song South Korea 18 463 1.6× 25 0.1× 70 0.3× 102 0.7× 53 0.5× 72 1.2k

Countries citing papers authored by Tomas Mow

Since Specialization
Citations

This map shows the geographic impact of Tomas Mow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Mow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Mow more than expected).

Fields of papers citing papers by Tomas Mow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Mow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Mow. The network helps show where Tomas Mow may publish in the future.

Co-authorship network of co-authors of Tomas Mow

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Mow. A scholar is included among the top collaborators of Tomas Mow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Mow. Tomas Mow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pognan, François, Mario Beilmann, Harrie C. M. Boonen, et al.. (2023). The evolving role of investigative toxicology in the pharmaceutical industry. Nature Reviews Drug Discovery. 22(4). 317–335. 132 indexed citations breakdown →
2.
Mow, Tomas, Nils Dragsted, M.L. Laursen, et al.. (2020). Is there a role for the no observed adverse effect level in safety pharmacology?. Journal of Pharmacological and Toxicological Methods. 105. 106917–106917. 11 indexed citations
3.
Pugsley, Michael K., Simon Authier, John Koerner, et al.. (2018). An overview of the safety pharmacology society strategic plan. Journal of Pharmacological and Toxicological Methods. 93. 35–45. 4 indexed citations
4.
Laursen, M.L., Jan Kehler, Claus T. Christoffersen, et al.. (2017). Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats. British Journal of Pharmacology. 174(15). 2563–2575. 28 indexed citations
5.
Arlock, Per, Tomas Mow, Trygve Sjöberg, et al.. (2017). Ion currents of cardiomyocytes in different regions of the Göttingen minipig heart. Journal of Pharmacological and Toxicological Methods. 86. 12–18. 10 indexed citations
6.
Persson, Mikael, et al.. (2014). High‐Content Analysis/Screening for Predictive Toxicology: Application to Hepatotoxicity and Genotoxicity. Basic & Clinical Pharmacology & Toxicology. 115(1). 18–23. 39 indexed citations
7.
Mow, Tomas, Kristen Frederiksen, & Morten B. Thomsen. (2014). Assessment of anti-arrhythmic activity of antipsychotic drugs in an animal model: Influence of non-cardiac α1-adrenergic receptors. European Journal of Pharmacology. 748. 10–17. 8 indexed citations
8.
Persson, Mikael, et al.. (2013). A high content screening assay to predict human drug-induced liver injury during drug discovery. Journal of Pharmacological and Toxicological Methods. 68(3). 302–313. 101 indexed citations
9.
Hornberg, Jorrit J., et al.. (2013). Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how. Drug Discovery Today. 19(8). 1131–1136. 78 indexed citations
10.
Hornberg, Jorrit J., et al.. (2013). Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies. Drug Discovery Today. 19(8). 1137–1144. 39 indexed citations
11.
Laursen, M.L., Morten Grunnet, Søren‐Peter Olesen, Thomas Jespersen, & Tomas Mow. (2011). Keeping the rhythm — Pro-arrhythmic investigations in isolated Göttingen minipig hearts. Journal of Pharmacological and Toxicological Methods. 64(2). 134–144. 8 indexed citations
12.
Laursen, M.L., Søren‐Peter Olesen, Morten Grunnet, Tomas Mow, & Thomas Jespersen. (2010). Characterization of cardiac repolarization in the Göttingen minipig. Journal of Pharmacological and Toxicological Methods. 63(2). 186–195. 22 indexed citations
13.
Mow, Tomas, et al.. (2008). Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of α1-adrenoceptor function. Psychopharmacology. 199(1). 15–27. 26 indexed citations
14.
Pouzet, Bruno, et al.. (2003). Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human. Pharmacology Biochemistry and Behavior. 75(1). 133–140. 122 indexed citations
15.
Mow, Tomas, et al.. (1999). Species differences in expression of angiotensin II receptors and angiotensin-converting enzyme in human, canine and rat mitral valve leaflets. Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 124(1). 11–17. 7 indexed citations
16.
Olsen, Lisbeth H., Tomas Mow, J. Koch, & Henrik D. Pedersen. (1999). Heart rate variability in young, clinically healthy Dachshunds: influence of sex, mitral valve prolapse status, sampling period and time of day. Journal of Veterinary Cardiology. 1(2). 7–16. 90 indexed citations
17.
Pedersen, Henrik D., Lisbeth H. Olsen, Tomas Mow, & Niels Juel Christensen. (1999). Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions. Research in Veterinary Science. 66(1). 11–17. 36 indexed citations
18.
Pedersen, Henrik D., Jens Häggström, T. Falk, et al.. (1999). Auscultation in Mild Mitral Regurgitation in Dogs: Observer Variation, Effects of Physical Maneuvers, and Agreement with Color Doppler Echocardiography and Phonocardiography. Journal of Veterinary Internal Medicine. 13(1). 56–64. 103 indexed citations
19.
Mow, Tomas & Henrik D. Pedersen. (1999). Increased Endothelin-Receptor Density in Myxomatous Canine Mitral Valve Leaflets. Journal of Cardiovascular Pharmacology. 34(2). 254–260. 45 indexed citations
20.
Pedersen, Henrik D. & Tomas Mow. (1998). Hypomagnesemia and Mitral Valve Prolapse in Cavalier King Charles Spaniels. Journal of Veterinary Medicine Series A. 45(1-10). 607–614. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026